Navigation Links
AGU journal highlights -- Sept. 6, 2007
Date:9/10/2007

er pole and downwelling and heating at the winter pole. This circulation creates extremely cold temperatures at the top of the mesosphere above the summer pole, often causing ice clouds called noctilucent clouds to form. Through data from the Swedish satellite Odin, Karlsson et al. study noctilucent clouds in order to estimate the average state of mesospheric circulation. They compare these conditions with the state of the stratosphere and find that an abundance of noctilucent clouds in the summer mesosphere coincides with cold winter stratospheric temperatures in the opposite hemisphere. This cross-hemispheric correlation operates such that fluctuations in the winter stratosphere lead the summer mesosphere response by several weeks. Although models have predicted such a correlation, the authors expect that the documentation of this phenomenon will help refine predictions of future atmospheric behavior.

Title:
Evidence for interhemispheric stratosphere-mesosphere coupling derived from noctilucent cloud properties

Authors:
B. Karlsson, H. Krnich, and J. Gumbel: Department of Meteorology, Stockholm University, Stockholm, Sweden.

Source:
Geophysical Research Letters (GRL) paper 10.1029/2007GL030282, 2007, http://dx.doi.org/10.1029/2007GL030282


'/>"/>

Contact: Peter Weiss
pweiss@agu.org
202-777-7507
American Geophysical Union
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology news :

1. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
2. Recent breakthroughs in common adult leukemia highlighted in New England Journal of Medicine
3. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
4. Open Access journals get impressive impact factors
5. Funding and bureaucracy, not access to journals, are chief obstacles to scientific productivity
6. New journal article urges use of animal serum-free media for growing live cells
7. Impressive new Impact Factors for BioMed Centrals open-access journals
8. Public Library of Science to launch new, open access journal on neglected tropical diseases
9. Are journal rankings distorting science?
10. New book highlights worlds borderless conservation areas
11. Learning to love bacteria: Stanford scientist highlights bugs benefits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2015)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its second quarter ended June 30, 2015.  ... a decrease of 33% compared to $6.8 million in the ... of 2015 was $0.3 million, or $0.01 per diluted share, ... in the same period a year ago.  ...
(Date:7/21/2015)... Connecticut , July 21, 2015  NXT-ID, ... "Company"), a biometric authentication company focused on the ... Wocket® smart wallet, announces that it has filed ... System and Method. This invention ... not only authorizes an account, but also the ...
(Date:7/13/2015)... Calif. , July 13, 2015 ... developer of human interface solutions, today announced sampling ... touch and display driver integration (TDDI) product targeting ... the first to combine Synaptics , best-in-class ... proven display driver technology developed in the company,s ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3
... Researchers with the International Agency for Research on Cancer ... significantly more likely to have several high-risk forms of ... not have lung cancer. These results, which were presented ... 2-6, indicate that HPV antibodies are substantially increased in ...
... In the largest study of its kind, researchers from ... new genes linked to late-onset Alzheimer,s disease. Each of these ... form of the disease, and together they offer a portal ... find ways to determine who is at risk of developing ...
... long been associated with religious rituals, diets, and political ... Intermountain Medical Center Heart Institute demonstrates that routine periodic ... heart. Today, research cardiologists at the Intermountain Medical ... lowers one,s risk of coronary artery disease and diabetes, ...
Cached Biology News:Lung cancer risk rises in the presence of HPV antibodies 2Alzheimer’s disease consortium identifies four new genes for Alzheimer’s disease risk 2Alzheimer’s disease consortium identifies four new genes for Alzheimer’s disease risk 3Study finds routine periodic fasting is good for your health, and your heart 2Study finds routine periodic fasting is good for your health, and your heart 3
(Date:7/30/2015)... ... , ... The 2015 Market Research Report on the Global Propanol Industry ... Propanol market with a focus on the Chinese situation. Major companies included in the ... Chemical, Sanofi, Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. , The report ...
(Date:7/30/2015)... ... July 30, 2015 , ... Leading regenerative ... study of its canine osteoarthritis stem cell product, currently under development for FDA ... and will be marketed in the US by Aratana. This product, termed AT-016, ...
(Date:7/30/2015)... July 30, 2015   Senomyx , Inc. (NASDAQ: ... science technologies to discover, develop, and commercialize novel flavor ... today reported financial results for the second quarter 2015. ... 2015, we remain on track to achieve our commercial ... Executive Officer of the Company. "Since our last quarterly ...
(Date:7/30/2015)... COPENHAGEN, Denmark , July 30, 2015 /PRNewswire/ ... a biotechnology company that applies its innovative TransCon ... announced positive top-line results from a six-month Phase ... of once-weekly TransCon Growth Hormone in 53 treatment-naïve, ... "We are extremely pleased with the ...
Breaking Biology Technology:Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
... 23 BioElectronics,Corporation, (Pink Sheets: BIEL), announced ... signed an agreement for the distribution of,ActiPatch(TM) ... October 10th. TSS Medical joins the ... BioElectronics has signed agreements in place and,shipping ...
... Scientific ... ... 23 /PRNewswire-FirstCall/,-- TopSpin Medical (TASE: TOPMD) announced today that the ... Resonance Imaging System During Coronary Endovascular,Catheterization (TOPIMAGE) demonstrated the safety ...
... 22 /PRNewswire-FirstCall/ - YM BioSciences Inc.,(AMEX: YMI ... that identifies,develops and commercializes differentiated products for patients ... adopted a renewed,Shareholder Rights Plan Agreement. The Rights ... shareholders in connection with any take-over offer,for the ...
Cached Biology Technology:BioElectronics Corporation Announces Distribution Agreement With TSS Medical of Italy 2Clinical Study Findings Show Safety and Procedure Success for TopSpin IntraVascular MRI Catheter for the Coronary Arteries 2Clinical Study Findings Show Safety and Procedure Success for TopSpin IntraVascular MRI Catheter for the Coronary Arteries 3YM Biosciences announces adoption of renewed Shareholders' Rights Plan 2YM Biosciences announces adoption of renewed Shareholders' Rights Plan 3
Dnase and Rnase free...
TLN2 Antibody...
Mouse monoclonal [0.N.305] to G protein alpha - BSA and Azide free ( Abpromise for all tested applications). Antigen: Partially purified G protein alpha from rat brain. Entrez GeneID: 2778 ...
Rabbit polyclonal to VEGF Receptor 2 (phospho Y1214) ( Abpromise for all tested applications). entrezGeneID: 3791 SwissProtID: P35968...
Biology Products: